Invero Pharma, Inc.
Invero Pharma, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest | Out-of-Hospital Cardiac Arrest, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, brain disorder, brain injury, cardiac arrest, cardiovascular disorder, central nervous system disorder, heart disorder, ischemia reperfusion injury, nervous system disorder, post-cardiac arrest syndrome, vascular disorder | Not yet recruiting | Phase 3 | 2025-04-03 | NCT03176186 |